These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 11028343)

  • 1. [Future antihypertensive drugs].
    Hashimoto K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():297-300. PubMed ID: 11028343
    [No Abstract]   [Full Text] [Related]  

  • 2. Low concentrations of ouabain induce vascular smooth muscle cell proliferation.
    Aydemir-Koksoy A; Allen JC
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):341-5. PubMed ID: 11355010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP dependent and myosin light chain kinase: relationship to altered vascular reactivity in hypertension and development of direct pharmacological modulators.
    Silver PJ
    Prog Clin Biol Res; 1987; 245():233-49. PubMed ID: 3685014
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tetrandrine on cardiac and vascular remodeling.
    Rao MR
    Acta Pharmacol Sin; 2002 Dec; 23(12):1075-85. PubMed ID: 12466044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
    Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G
    Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of altered sodium, potassium pump activity.
    Mulvany MJ
    Scand J Clin Lab Invest Suppl; 1986; 180():40-8. PubMed ID: 3012761
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of Na(+)-K+ ATPase in cyclic GMP-mediated relaxation of canine pulmonary artery smooth muscle cells.
    Tamaoki J; Tagaya E; Nishimura K; Isono K; Nagai A
    Br J Pharmacol; 1997 Sep; 122(1):112-6. PubMed ID: 9298536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action.
    Quadri L; Bianchi G; Cerri A; Fedrizzi G; Ferrari P; Gobbini M; Melloni P; Sputore S; Torri M
    J Med Chem; 1997 May; 40(11):1561-4. PubMed ID: 9171865
    [No Abstract]   [Full Text] [Related]  

  • 9. Potassium effects on contraction in arterial smooth muscle mediated by Na+, K+-ATPase.
    Haddy FJ
    Fed Proc; 1983 Feb; 42(2):239-45. PubMed ID: 6295824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na,K-ATPase in excitation-contraction coupling of vascular smooth muscle from cattle.
    Preiss R; Banaschak H
    Acta Biol Med Ger; 1979; 38(1):83-96. PubMed ID: 229670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The sodium-potassium pump in hypertension. Mechanisms of action of potassium].
    Haddy FJ
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():67-72. PubMed ID: 6329119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium transport in vascular smooth muscle cells from resistance vessels.
    Aalkjaer C; Mulvany MJ
    Scand J Clin Lab Invest Suppl; 1986; 180():49-53. PubMed ID: 3012762
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tetrandrine on myocardial Na+, K(+)-ATPase in renovascular hypertensive rats.
    Chen NH; Wang YL; Ding JH
    Zhongguo Yao Li Xue Bao; 1991 Nov; 12(6):488-93. PubMed ID: 1668564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
    Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.
    Ferrari P; Torielli L; Ferrandi M; Padoani G; Duzzi L; Florio M; Conti F; Melloni P; Vesci L; Corsico N; Bianchi G
    J Pharmacol Exp Ther; 1998 Apr; 285(1):83-94. PubMed ID: 9535997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical effects of GYKI-12 743.
    Bakonyi A; Tömösközi Z; Heiczman A; Horváth EJ; Arányi P; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():19-20. PubMed ID: 2164749
    [No Abstract]   [Full Text] [Related]  

  • 18. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.
    Abramowitz J; Dai C; Hirschi KK; Dmitrieva RI; Doris PA; Liu L; Allen JC
    Circulation; 2003 Dec; 108(24):3048-53. PubMed ID: 14638550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic control of vascular smooth muscle cells.
    Haddy FJ
    Kidney Int Suppl; 1988 Sep; 25():S2-8. PubMed ID: 2846936
    [No Abstract]   [Full Text] [Related]  

  • 20. Alteration of cellular calcium metabolism as primary cause of hypertension.
    Sprenger KB
    Clin Physiol Biochem; 1985; 3(4):208-20. PubMed ID: 2990801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.